Back to newsMBX Biosciences, Inc. <MBX.O>: Truist Securities raises target price to $88 from $70MMBX•2026-08-10Related NewsAArcher to acquire Boeing's Wisk and two subsidiaries for near 20% equity stakeACHR•2026-08-10QQuanterix Q2 revenue rises 34% but cuts 2026 outlookQTRX•2026-08-10POutdoor Holding Company Q1 EPS USD 0.02POWW•2026-08-10TTelomir plans Phase 1/2 trial of Telomir-Zn in triple-negative breast cancer after preclinical publicationTELO•2026-08-10
MBX•
